Companies / Kala Pharmaceuticals
Kala Pharmaceuticals
United States
KALA BIO is a biopharmaceutical company that develops therapies and utilizes data and AI technology for clinical research and enterprise applications.
Kala Pharmaceuticals, based in United States, has 3 investors on file, among them Longitude Capital, Lux Capital and Ysios Capital. Its latest round on record is Debt, 17 Dec 2025. Its site was last checked 12 Nov 2026: site answers.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
3 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Kala Pharmaceuticals and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Longitude Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/kalarx.com/investors
# also
GET /v1/companies/kalarx.com
GET /v1/companies/kalarx.com/news